<unk>  (Autologous Lymphoid Effector Cells Specific Against Tumor cells) technology is a novel method of epigenetic cancer immunotherapy being used by the company CytoVac. It uses a patient's own immune system to target tumor cells in prostate cancer, glioblastomas, and potentially pancreatic cancer.<unk>  research, directed by Alexei Kirken and Karine Dzhandzhugazyan, has led to several clinical trials.
ALECSAT
DRACO
ReFLEX
MOSQUITO
SCAPER
CORE-OM
FCM 
OHVIRA